1
Eric First, M.D.
First Eric R: Botulinum toxin therapy for skin disorders. Allergan, August 23, 2006: EP1691830-A1 (5 worldwide citation)

Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.


2
Eric First, M.D.
First Eric R, Irvine Ryan A: Methods for enhancing skin treatments. Allergan, First Eric R, Irvine Ryan A, NASSIF Claude, August 9, 2007: WO/2007/089454 (3 worldwide citation)

The present invention relates to methods for enhancing the result of a skin treatment for a human patient. In some embodiments, the methods comprise the step of administering a neurotoxin to a skin area designated for the skin treatment. The skin treatment includes the application of a dermatologic ...


3
Eric First, M.D.
First Eric R, Irvine Ryan A: Methods for enhancing therapeutic effects of a neurotoxin. Allergan, First Eric R, Irvine Ryan A, NASSIF Claude, August 2, 2007: WO/2007/087154 (2 worldwide citation)

The present invention relates to methods for enhancing the therapeutic effects of a neurotoxin, e.g., a botulinum toxin, where the methods comprise a 'wash-down' (e.g., a decreased intake) of a current pain medication and an administration of a neurotoxin. In some embodiments, the present inventions ...


4
Eric First, M.D.
First Eric R: Botulinum toxin therapy for skin disorders. Allergan, First Eric R, DONOVAN Stephen, June 23, 2005: WO/2005/056050 (2 worldwide citation)

Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder, such as a wart, corn, callus or bunion.


5
Eric First, M.D.
First Eric R: Clostridial toxins for treating eye disorders. Allergan, First Eric R, DONOVAN Stephen, December 29, 2004: WO/2004/112830 (2 worldwide citation)

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivi ...


6
Eric First, M.D.
First Eric R: Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods. Allergan, First Eric R, DONOVAN Stephen, April 13, 2006: WO/2006/039014 (1 worldwide citation)

Cosmetic compositions include a Clostridial neurotoxin component and a microsphere component. In certain compositions, the composition includes a botulinum toxin and a plurality of swellable microspheres. The compositions are administered to individuals, by injection and the like, to treat a cosmeti ...


7
Eric First, M.D.
First Eric R: Botulinum toxin therapy for skin disorders. Allergan, August 22, 2007: EP1820510-A1

Use of a botulinum toxin for the manufacture of a medicament for treating a skin disorder selected from the group consisting of a neuroma, hammertoe, dermatofibroma, mole, granuloma or a keratose.


8
Eric First, M.D.
DURKEE Shane E, BEKE Pradnya, FIRST Eric R, PATEL Ashish: SUPPLÉMENT EN CALCIUM, CALCIUM SUPPLEMENT. BAYER HEALTHCARE, DURKEE Shane E, BEKE Pradnya, FIRST Eric R, PATEL Ashish, BULLITT Richard S, October 4, 2012: WO/2012/134590

An oral dosage form for administration to an animal comprising a biologically utilizable form of calcium and a extended release system that maintains the calcium level in the animal's bloodstream at a substantially beneficial level for a defined period of time.


9
Eric First, M.D.
First Eric R: Use of a botulinum toxin for treating a buttock deformity. Allergan, First Eric R, DONOVAN Stephen, March 16, 2006: WO/2006/029287

Methods for treating a buttock deformity or for preventing development of a buttock deformity by local administration of a Clostridial toxin, such as a botulinum neurotoxin, to a buttock deformity or to the vicinity of a buttock deformity.


10
Eric First, M.D.
First Eric R: Stretch mark treatment with botulinum toxic. Allergan, First Eric R, DONOVAN Stephen, March 16, 2006: WO/2006/028724

Methods for treating stretch marks by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a stretch mark.



Click the thumbnails below to visualize the patent trend.